JP2024540163A5 - - Google Patents
Info
- Publication number
- JP2024540163A5 JP2024540163A5 JP2024525593A JP2024525593A JP2024540163A5 JP 2024540163 A5 JP2024540163 A5 JP 2024540163A5 JP 2024525593 A JP2024525593 A JP 2024525593A JP 2024525593 A JP2024525593 A JP 2024525593A JP 2024540163 A5 JP2024540163 A5 JP 2024540163A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- atoms
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273242P | 2021-10-29 | 2021-10-29 | |
| US63/273,242 | 2021-10-29 | ||
| PCT/US2022/078879 WO2023077070A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540163A JP2024540163A (ja) | 2024-10-31 |
| JP2024540163A5 true JP2024540163A5 (https=) | 2025-10-30 |
Family
ID=84363771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525593A Pending JP2024540163A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250011288A1 (https=) |
| EP (1) | EP4423068B1 (https=) |
| JP (1) | JP2024540163A (https=) |
| KR (1) | KR20240091018A (https=) |
| CN (1) | CN118510758A (https=) |
| ES (1) | ES3062200T3 (https=) |
| WO (1) | WO2023077070A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121605099A (zh) * | 2023-08-10 | 2026-03-03 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| TW202530177A (zh) * | 2023-10-13 | 2025-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 醯胺取代的環烷基類化合物、其製備方法及其在醫藥上的應用 |
| TW202543619A (zh) | 2023-12-15 | 2025-11-16 | 美商美國禮來大藥廠 | Ｒｘｆｐ１受體促效劑 |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
| WO2026064271A1 (en) * | 2024-09-23 | 2026-03-26 | Fmc Corporation | Substituted bicyclic amide derivatives as herbicides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2585054A1 (en) | 2010-06-24 | 2013-05-01 | Allergan, Inc. | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| US9452973B2 (en) * | 2012-05-04 | 2016-09-27 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| EP4259605A1 (en) * | 2020-12-08 | 2023-10-18 | Astrazeneca AB | 4-(2-fluoro-4-methoxy-5-3-(((1-methylcyclobutyl)methyl)carbamoyl)bicyclo[2.2.1]heptan-2-yl)carbamoyl)phenoxy)-1-methylcyclohexane-1-carboxylic acid derivatives and similar compounds as rxfp1 modulators for the treatment of heart failure |
-
2022
- 2022-10-28 ES ES22813850T patent/ES3062200T3/es active Active
- 2022-10-28 EP EP22813850.9A patent/EP4423068B1/en active Active
- 2022-10-28 WO PCT/US2022/078879 patent/WO2023077070A1/en not_active Ceased
- 2022-10-28 JP JP2024525593A patent/JP2024540163A/ja active Pending
- 2022-10-28 KR KR1020247017525A patent/KR20240091018A/ko active Pending
- 2022-10-28 CN CN202280083558.3A patent/CN118510758A/zh active Pending
- 2022-10-28 US US18/701,270 patent/US20250011288A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024540163A5 (https=) | ||
| JP2024543013A5 (https=) | ||
| JP2024540164A5 (https=) | ||
| JP2022519636A5 (https=) | ||
| JP2022544714A5 (https=) | ||
| JP6153971B2 (ja) | シクロアルキル基で置換されたイミダゾール誘導体 | |
| JP2024522990A5 (https=) | ||
| JP2008520589A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2021535174A5 (https=) | ||
| JP2022529315A5 (https=) | ||
| JP2024513227A5 (https=) | ||
| JP3179599B2 (ja) | 縮合ベンゼンオキシ酢酸誘導体およびそれらを有効成分として含有する薬剤 | |
| JP2021530560A5 (https=) | ||
| US7273883B2 (en) | Prostaglandin EP4 antagonist | |
| JP2025501509A5 (https=) | ||
| JP2022536160A5 (https=) | ||
| JP2649507B2 (ja) | オキシム誘導体、その製造方法およびそれを含有する医薬品 | |
| JP2021520394A5 (https=) | ||
| JP2984077B2 (ja) | スルホニルアミノ置換ビシクロ環系ヒドロキサム酸誘導体 | |
| JP2023546742A5 (https=) | ||
| JP2023531411A5 (https=) | ||
| JP2023533037A5 (https=) | ||
| JP2024522201A5 (https=) | ||
| AU670709B2 (en) | Novel cephalosporin antibiotics and processes for preparation thereof |